News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
753,079 Results
Type
Article (53203)
Company Profile (337)
Press Release (699539)
Section
Business (220695)
Career Advice (2898)
Deals (37591)
Drug Delivery (106)
Drug Development (86422)
Employer Resources (181)
FDA (17093)
Job Trends (15998)
News (372670)
Policy (35874)
Tag
Academia (2898)
Alliances (53210)
Alzheimer's disease (1318)
Approvals (17007)
Artificial intelligence (142)
Bankruptcy (381)
Best Places to Work (12128)
Biotechnology (238)
Breast cancer (129)
Cancer (1155)
Cardiovascular disease (107)
Career advice (2434)
Cell therapy (259)
Clinical research (68473)
Collaboration (409)
Compensation (202)
COVID-19 (2740)
C-suite (105)
Data (1152)
Diabetes (163)
Diagnostics (6565)
Drug pricing (94)
Earnings (90464)
Employer resources (158)
Events (119966)
Executive appointments (325)
FDA (17649)
Funding (367)
Gene therapy (195)
GLP-1 (663)
Government (4767)
Healthcare (20082)
Infectious disease (2829)
Inflammatory bowel disease (116)
Interviews (557)
IPO (16963)
Job creations (4242)
Job search strategy (2024)
Layoffs (461)
Legal (8901)
Lung cancer (187)
Manufacturing (193)
Medical device (13980)
Medtech (13985)
Mergers & acquisitions (20682)
Metabolic disorders (447)
Neuroscience (1620)
NextGen Class of 2024 (7153)
Non-profit (4897)
Northern California (1513)
Obesity (257)
Opinion (228)
Patents (110)
People (61696)
Phase I (21200)
Phase II (30010)
Phase III (22495)
Pipeline (467)
Postmarket research (2954)
Preclinical (9138)
Radiopharmaceuticals (250)
Rare diseases (238)
Real estate (6583)
Regulatory (23587)
Research institute (2568)
Resumes & cover letters (456)
Southern California (1333)
Startups (3898)
United States (14052)
Vaccines (618)
Weight loss (200)
Date
Today (137)
Last 7 days (744)
Last 30 days (3869)
Last 365 days (37345)
2024 (34259)
2023 (41849)
2022 (53156)
2021 (57861)
2020 (56714)
2019 (49917)
2018 (37818)
2017 (34756)
2016 (34879)
2015 (41055)
2014 (35374)
2013 (30825)
2012 (32824)
2011 (33433)
2010 (31843)
Location
Africa (935)
Arizona (210)
Asia (42184)
Australia (7621)
California (3425)
Canada (1304)
China (257)
Colorado (154)
Connecticut (160)
Europe (93632)
Florida (468)
Georgia (124)
Illinois (372)
Indiana (206)
Kansas (98)
Maryland (606)
Massachusetts (2716)
Michigan (175)
Minnesota (290)
New Jersey (987)
New York (980)
North Carolina (787)
Northern California (1513)
Ohio (144)
Pennsylvania (854)
South America (1316)
Southern California (1333)
Texas (476)
Washington State (374)
753,079 Results for "prophase labs inc formerly known as quigley corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
November 11, 2024
·
1 min read
Press Releases
ProPhase Labs Announces Pricing of Public Offering of Common Stock
November 8, 2024
·
4 min read
Business
Prophase Labs Inc. To Present First Quarter 2024 Financial Results on May 9
ProPhase Labs Inc., announced that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT.
May 2, 2024
·
1 min read
Press Releases
ProPhase Labs to Present at the 2024 ThinkEquity Conference
October 23, 2024
·
1 min read
Press Releases
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024
November 13, 2024
·
21 min read
Business
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today reported its financial and operational results for the three months ended March 31, 2024.
May 9, 2024
·
24 min read
Press Releases
ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
July 11, 2024
·
6 min read
Business
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
ProPhase Labs, Inc. today reported that Jason Karkus, one of the driving forces behind ProPhase Diagnostics, becomes President of Nebula Genomics, a wholly-owned subsidiary of ProPhase Labs.
January 30, 2024
·
5 min read
Pharm Country
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024
ProPhase Labs, Inc. today reported its progress on the commercialization of its breakthrough BE-Smart test for esophageal cancer.
April 10, 2024
·
7 min read
Pharm Country
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
ProPhase Labs, Inc. today announced positive preliminary results from its Equivir dietary supplement comprehensive trial.
February 14, 2024
·
5 min read
1 of 75,308
Next
